2026.02.05

SK bioscience Strengthens Global Pandemic Preparedness through Participation in Korea’s “100 Days Mission” Sim...

2026.02.03

SK bioscience Announces Preliminary FY2025 Results 2.4x Revenue Growth Year-over-Year Driven by IDT Turnaroun...

2026.02.03

SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute

2026.01.29

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbec...

2026.01.22

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding